Q1 2022 13F Holders as of 3/31/2022
-
Type / Class
-
Equity / Common Stock
-
Shares outstanding
-
334M
-
Number of holders
-
228
-
Total 13F shares, excl. options
-
155M
-
Shares change
-
+1.41M
-
Total reported value, excl. options
-
$2.57B
-
Value change
-
+$12.4M
-
Put/Call ratio
-
0.21
-
Number of buys
-
138
-
Number of sells
-
-94
-
Price
-
$16.65
Significant Holders of IOVANCE BIOTHERAPEUTICS, INC. - Common Stock (IOVA) as of Q1 2022
291 filings reported holding IOVA - IOVANCE BIOTHERAPEUTICS, INC. - Common Stock as of Q1 2022.
IOVANCE BIOTHERAPEUTICS, INC. - Common Stock (IOVA) has 228 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 155M shares
of 334M outstanding shares and own 46.26% of the company stock.
Largest 10 shareholders include VANGUARD GROUP INC (12.3M shares), PERCEPTIVE ADVISORS LLC (12.2M shares), WELLINGTON MANAGEMENT GROUP LLP (11.3M shares), Avoro Capital Advisors LLC (9.13M shares), BlackRock Inc. (7.43M shares), STATE STREET CORP (6.85M shares), ORBIMED ADVISORS LLC (6.63M shares), FARALLON CAPITAL MANAGEMENT LLC (6.18M shares), Avidity Partners Management LP (6.04M shares), and FRANKLIN RESOURCES INC (5.39M shares).
This table shows the top 228 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.